Unknown

Dataset Information

0

Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.

ABSTRACT:

SUBMITTER: Madsen KS 

PROVIDER: S-EPMC6472662 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.
| S-EPMC7561209 | biostudies-literature
Unknown Initial combination therapy for patients with type 2 diabetes mellitus: considerations for metformin plus linagliptin.
| S-EPMC3884752 | biostudies-literature
Unknown Metformin monotherapy for adults with type 2 diabetes mellitus.
| S-EPMC7386876 | biostudies-literature
Unknown Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.
| S-EPMC3216433 | biostudies-literature
Unknown Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
| S-EPMC5033027 | biostudies-literature
Unknown Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.
| S-EPMC4282288 | biostudies-literature
Unknown Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus.
| S-EPMC3378710 | biostudies-literature
Unknown Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial.
| S-EPMC4771973 | biostudies-literature
Unknown Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia.
| S-EPMC8111283 | biostudies-literature
Unknown Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus.
| S-EPMC4202665 | biostudies-literature